Aarisepharma (@aarisepharma) | GuestCountry Author Profile

aarise pharma

@aarisepharma

For pharmaceutical buyers, supplier selection starts with evidence that can survive an audit. GMP expectations provide a practical baseline for assessing active

2 articles 0 followers

How to Choose Peptide CDMO Partners for Clinical Development and Commercial Manufacturing

Peptide drug development involves several manufacturing decisions that can influence product quality, development timelines, and long-term supply reli...

Which Peptide CDMOs Scale Clinical Batches?

We see peptide programmes become harder to manage when impurity separation and analytical control lag behind synthesis development. Peptide manufactur...